CTRI/2020/11/029043
Not yet recruiting
Phase 3
Comparison between rectal versus sublingual misoprostol before cesarean sections to control intra- and postoperative blood loss: a double blind, randomized controlled study.
IPGMER0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: O721- Other immediate postpartum hemorrhageHealth Condition 2: O720- Third-stage hemorrhage
- Sponsor
- IPGMER
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Term pregnancy, singleton pregnancy, scheduled for elective lower segment caesarean section under spinal anaesthesia.
Exclusion Criteria
- •Hb% \< 10 gm%, multifetal gestation, antepartum haemorrhage, polyhydramnios, two or more previous caesarean section, hypertension in pregnancy, history of heart, liver and renal disorder, active thromboembolic disease or previous history of thromboembolism, hypersensitivity to prostaglandins.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparison the effect of rectal and oral misoprostol in First Trimester of Pregnancy Induced AbortioIRCT2017042533635N1deputy of research and technology of zahedan university of medical sciences140
Completed
Phase 3
A comparison of rectal and sublingual Misoprostol on Post -Partum haemorrhage during cesarean sectioIRCT20190204042614N1Yazd University of Medical Sciences80
Completed
Not Applicable
Study on compare of sublingual, rectal and vaginal misoprostol for cervical priming 12 hours before hysteroscopyCondition 1: Patients who are candidates for hysteroscopy. Condition 2: Patients who are candidates for hysteroscopy.Noninflammatory disorder of uterus, unspecifiedInflammatory disease of uterus, unspecifiedIRCT201105296626N1Tabriz University of medical science120
Completed
Not Applicable
Misoprostol in therapeutic abortioTherapeutic abortion.Therapeutic AbortionIRCT2013040912958N1Tehran University of Medical Sciences480
Completed
Phase 4
Comparison Between Vaginal and Sublingual Misoprostol 50 µg for Cervical Ripening Prior to Induction of LaborCervical RipeningNCT02732522Universidad de la Republica102